Reaction

Vascular Access Site Complication reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 242 reports · 5 co-occurring drugs

As of the last recalculation, Vascular Access Site Complication appears in 242 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is ADRENALINUM (PRR 323.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Adrenalinum95323.5324.2
Epinephrine95204.8205.1
Hydroxyzine Hydrochloride1175.375.4
Hydroxyzine Hydrochloride Oral1175.375.4
Fexofenadine Hydrochloride1354.354.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.